Dose-Escalation Study of Azacitidine Followed By High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in High-Risk Acute Myeloid Leukemia (AML)

被引：2
|
作者：
Karimi, Yasmin H. [1 ]
Jain, Nitin [2 ]
Green, Margaret [1 ]
Godley, Lucy A. [1 ]
Weiner, Howie Lawrence [1 ]
Malnassy, Gregory [1 ]
Fulton, Noreen [1 ]
Artz, Andrew [1 ]
Liu, Hongtao [1 ]
Thirman, Michael J. [1 ]
Daunov, Michael [1 ]
Larson, Richard A. [1 ]
Stock, Wendy [1 ]
Odenike, Olatoyosi [1 ]
机构：
[1] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.118.118
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] High Dose Cytarabine (HiDAC) and Mitoxantrone (MITO) Is An Effective Induction Therapy for High-Risk Acute Myeloid Leukemia (AML).
    Larson, Sarah
    Campbell, Nicholas
    Huo, Dezheng
    Artz, Andrew
    Zhang, Yanming
    Gajria, Devika
    Green, Margaret
    Rahimova, Gamar
    Weiner, Howard
    Torres, Monica
    Odenike, Olatoyosi
    Godley, Lucy A.
    Rich, Elizabeth Shima
    Thirman, Michael
    Larson, Richard A.
    Stock, Wendy
    BLOOD, 2009, 114 (22) : 434 - 434
  • [2] Combination of Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML) Is Feasible and Tolerable
    Wang, Amy Y.
    Weiner, Howie Lawrence
    Green, Margaret
    Larson, Richard A.
    Odenike, Olatoyosi
    Artz, Andrew
    Godley, Lucy A.
    Thirman, Michael J.
    Churpek, Jane E.
    Curran, Emily K.
    Pettit, Kristen
    Stock, Wendy
    Liu, Hongtao
    BLOOD, 2016, 128 (22)
  • [3] A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia
    Cahill, Kirk E.
    Karimi, Yasmin H.
    Karrison, Theodore G.
    Jain, Nitin
    Green, Margaret
    Weiner, Howard
    Fulton, Noreen
    Kadri, Sabah
    Godley, Lucy A.
    Artz, Andrew S.
    Liu, Hongtao
    Thirman, Michael J.
    Le Beau, Michelle M.
    McNerney, Megan E.
    Segal, Jeremy
    Larson, Richard A.
    Stock, Wendy
    Odenike, Olatoyosi
    BLOOD ADVANCES, 2020, 4 (04) : 599 - 606
  • [4] Final Results from a Phase I Trial Combining Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML)
    Wang, Amy
    Weiner, Howard
    Larson, Richard A.
    Odenike, Olatoyosi
    Artz, Andrew S.
    Bishop, Michael R.
    Godley, Lucy
    Thirman, Michael
    Kosuri, Satyajit
    Churpek, Jane
    Curran, Emily K.
    Pettit, Kristen
    Stock, Wendy
    Liu, Hongtao
    BLOOD, 2018, 132
  • [5] High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk Acute Myeloid Leukemia (AML)
    Larson, Sarah M.
    Campbell, Nicholas P.
    Huo, Dezheng
    Artz, Andrew
    Zhang, Yanming
    Gajria, Devika
    Green, Margaret
    Weiner, Howie
    Daugherty, Christopher
    Odenike, Olatoyosi
    Godley, Lucy A.
    Hyjek, Elizabeth
    Gurbuxani, Sandeep
    Thirman, Michael
    Sipkins, Dorothy
    Van Besien, Koen
    Larson, Richard A.
    Stock, Wendy
    LEUKEMIA & LYMPHOMA, 2012, 53 (03) : 445 - 450
  • [6] INCREASED ABILITY TO TRANSPLANT AND IMPROVED SURVIVAL IN PATIENTS WITH HIGH RISK ACUTE MYELOID LEUKEMIA (AML) AFTER INDUCTION WITH HIGH DOSE CYTARABINE AND MITOXANTRONE (HIDAC/MITO)
    Ramanathan, M.
    Cerny, Y.
    Raffel, G.
    Petrillo-Deluca, L.
    Tarrasky, N.
    Nath, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S291 - S292
  • [7] Induction chemotherapy with high-dose cytarabine and mitoxantrone in elderly acute myeloid leukemia (AML) patients.
    Ramanathan, Muthalagu
    Cerny, Jan
    Raffel, Glen
    Walsh, William Vincent
    Woda, Bruce
    Miron, Patricia
    Nath, Rajneesh
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
    Wang, Amy Y.
    Weiner, Howard
    Green, Margaret
    Chang, Hua
    Fulton, Noreen
    Larson, Richard A.
    Odenike, Olatoyosi
    Artz, Andrew S.
    Bishop, Michael R.
    Godley, Lucy A.
    Thirman, Michael J.
    Kosuri, Satyajit
    Churpek, Jane E.
    Curran, Emily
    Pettit, Kristen
    Stock, Wendy
    Liu, Hongtao
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11 : 4
  • [9] A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
    Amy Y. Wang
    Howard Weiner
    Margaret Green
    Hua Chang
    Noreen Fulton
    Richard A. Larson
    Olatoyosi Odenike
    Andrew S. Artz
    Michael R. Bishop
    Lucy A. Godley
    Michael J. Thirman
    Satyajit Kosuri
    Jane E. Churpek
    Emily Curran
    Kristen Pettit
    Wendy Stock
    Hongtao Liu
    Journal of Hematology & Oncology, 11
  • [10] High-dose cytarabine induction for acute myeloid leukemia
    Shepherd, JD
    Barnett, MJ
    Phillips, GL
    BLOOD, 1996, 88 (02) : 754 - 754
12345